← Leaderboards
Louisa Degenhardt
University Of New South Wales
$1,115,956
Attributed
$2,065,773
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $736.1K · FY2017–25$1M$750K$500K$250K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,065,773 · 2
By mechanism
R01$2,065,773 · 2
Top collaborators
- Natasha Martin2 shared
- Joshua Adam Barocas1 shared
- Matt Hickman1 shared
Most similar at University Of New South Wales
Same institution · by research overlap
- Gail Matthews$3,728,356
- Perminder S Sachdev$7,369,069
- Matt Hickman$229,551
Others in their field
Other Emerging Leaders on “Link”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$143,577,666
- Susan M Landau · University Of California Berkeley$47,252,026
- John Damon Chodera · Sloan-Kettering Inst Can Research$34,507,271
- Kathleen Maletic Neuzil · Emory University$25,301,215
- Anthony Philippakis · University Of California Santa Cruz$23,897,237
- Bronwen Shaw · Medical College Of Wisconsin$18,756,649
Research focus
LinkPharmaceutical PreparationsOverdose DeathResponseBuprenorphinePrescription OpioidOverdoseScale UpPersonsProviderMortalityUnited StatesCessation Of LifeMethadoneDrug AbuseNew South WalesEventOpioid Use DisorderOpioid EpidemicOpioid Agonist TherapyAftercareAdverse EventCriminal JusticeMachine Learning
Grant awards (6)
TRANSFORM - Transforming the evidence base on estimating prevalence of opioid use disorder and expanded access to interventions to prevent drug related deaths: an international data linkage study$736,072
R01 · FY2025 · DA · contact PI
TRANSFORM - Transforming the evidence base on estimating prevalence of opioid use disorder and expanded access to interventions to prevent drug related deaths: an international data linkage study$688,653
R01 · FY2024 · DA · contact PI
Using existing data to understand and ameliorate risk in opioid agonist therapy$197,617
R01 · FY2019 · DA · contact PI
Using existing data to understand and ameliorate risk in opioid agonist therapy$48,600
R01 · FY2019 · DA · contact PI
Using existing data to understand and ameliorate risk in opioid agonist therapy$197,617
R01 · FY2018 · DA · contact PI
Using existing data to understand and ameliorate risk in opioid agonist therapy$197,214
R01 · FY2017 · DA · contact PI